NeOnc Technologies Granted Investigational New Drug Status From Abu Dhabi's Department Of Health For NEO100 To Treat Non-Invasive Nose-To-Brain Delivery

뉴스 본문을 불러오고 있어요.

NeOnc Technologies Granted Investigational New Drug Status From Abu Dhabi's Department Of Health For NEO100 To Treat Non-Invasive Nose-To-Brain Delivery | 웨이프 WAPE

NeOnc Technologies Granted Investigational New Drug Status From Abu Dhabi's Department Of Health For NEO100 To Treat Non-Invasive Nose-To-Brain Delivery

기사 요약

관련 종목

댓글 —